Pat Buchanan tells readers that a collision between Trump and Director Mueller is inevitable. No special counsels with this much fanfare have failed, in Pat’s words, to “take scalps.” That’s not good news for the Trump administration. Making it worse, Pat says, is Trump’s poor treatment of one of his best allies in the Justice Department, Jeff Sessions. Pat writes:
Given the bravery he showed in stepping out front as the first senator to endorse Donald Trump, Jeff Sessions deserves better from his boss than the Twitter-trashing he has lately received.
The attorney general has not only been loyal to Trump and his agenda, he has the respect and affection of ex-colleagues in Congress and, more broadly, of populists and conservatives nationally.
Trump’s tweets about Sessions are only demoralizing his base.
Yet the president is not wrong to be exasperated and enraged.
A yearlong FBI investigation into Russian hacking has failed to produce a single indictment. Yet the president watches impotently as a special counsel pulls together a lethal force, inside his own administration, whose undeclared ambition is to bring him down.
Trump’s behavior suggests that he sees the Mueller threat as potentially mortal.
This is not a witch hunt. It is an Easter egg hunt on the White House lawn, where the most colorful eggs are likely to be the tax returns and the financial records of Trump, who built a real estate empire in a town where winners brag about how they gutted the losers.
Every enemy of Trump is going to be dropping the dime on him to Mueller. Moreover, there is no history of special counsels being appointed and applauded by the press, who went home without taking scalps.
We are headed for a collision between President Trump and Director Mueller.
Read more here at The American Conservative.
Pat Buchanan on The Sean Hannity Radio Show (7/27/2017)
Latest posts by Richard C. Young (see all)
- VIDEO: Mojo Boogie – Sonny Landreth, South of I-10 - January 17, 2020
- DNC/CNN Terrified Sanders Can’t Beat Trump - January 16, 2020
- Should You Take the Dividend Blood Oath? - January 16, 2020